Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

CEFAZOLIN CRS (150 MG)

CEFAZOLIN CRS (150 MG)

25953-19-9

DISCOVER
CEFIXIME CRS (200 MG)

CEFIXIME CRS (200 MG)

79350-37-1

DISCOVER
CEFOPERAZONE DIHYDRATE CRS (110 MG)

CEFOPERAZONE DIHYDRATE CRS (110 MG)

62893-19-0

DISCOVER
CEFOPERAZONE SODIUM - REFERENCE SPECTRUM (N/A)

CEFOPERAZONE SODIUM - REFERENCE SPECTRUM (N/A)

NA

DISCOVER
CEFOTAXIME SODIUM CRS (20 MG)

CEFOTAXIME SODIUM CRS (20 MG)

64485-93-4

DISCOVER
CEFOXITIN SODIUM CRS (100 MG)

CEFOXITIN SODIUM CRS (100 MG)

33564-30-6

DISCOVER
CEFRADINE CRS (300 MG)

CEFRADINE CRS (300 MG)

38821-53-3

DISCOVER
CEFTAZIDIME CRS (70 MG)

CEFTAZIDIME CRS (70 MG)

78439-06-2

DISCOVER
CEFTRIAXONE SODIUM CRS (100 MG)

CEFTRIAXONE SODIUM CRS (100 MG)

104376-79-6

DISCOVER
CEFTRIAXONE IMPURITY A CRS (10 MG)

CEFTRIAXONE IMPURITY A CRS (10 MG)

NA

DISCOVER
CEFUROXIME AXETIL CRS (70 MG)

CEFUROXIME AXETIL CRS (70 MG)

64544-07-6

DISCOVER
CEFUROXIME SODIUM CRS (70 MG)

CEFUROXIME SODIUM CRS (70 MG)

56238-63-2

DISCOVER